Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-cash Items: 2020-2022

Historic Non-cash Items for Caribou Biosciences (CRBU) over the last 1 years, with Jun 2022 value amounting to $1.9 million.

  • Caribou Biosciences' Non-cash Items fell 63.44% to $1.9 million in Q2 2022 from the same period last year, while for Jun 2022 it was $1.9 million, marking a year-over-year decrease of 63.44%. This contributed to the annual value of $50.1 million for FY2021, which is 622.83% up from last year.
  • As of Q2 2022, Caribou Biosciences' Non-cash Items stood at $1.9 million, which was down 94.04% from $32.0 million recorded in Q1 2022.
  • Caribou Biosciences' 5-year Non-cash Items high stood at $50.1 million for Q4 2021, and its period low was $1.9 million during Q2 2022.
  • In the last 3 years, Caribou Biosciences' Non-cash Items had a median value of $6.1 million in 2020 and averaged $16.9 million.
  • In the last 5 years, Caribou Biosciences' Non-cash Items surged by 622.83% in 2021 and then slumped by 63.44% in 2022.
  • Over the past 3 years, Caribou Biosciences' Non-cash Items (Quarterly) stood at $6.9 million in 2020, then soared by 622.83% to $50.1 million in 2021, then slumped by 63.44% to $1.9 million in 2022.
  • Its Non-cash Items was $1.9 million in Q2 2022, compared to $32.0 million in Q1 2022 and $50.1 million in Q4 2021.